Table 3 Comparison of the clinical characteristics between Group 1A (cases in which transparency was maintained after recovery from rejection, n = 25) and Group 1B (cases in which the decompensation occurring after transparency recovered, n = 12)
Group 1A | Group 1B | OR | P-Value | |
|---|---|---|---|---|
mean ± SD | mean ± SD | (95% CI) | ||
n (%) | n (%) | |||
Age (years) | 58.4 ± 17.4 | 61.5 ± 10.8 | 0.99 (0.94–1.03) | 0.57 |
Sex | ||||
Male | 17 (68.0) | 6 (50.0) | 2.13 (0.52–8.70) | 0.29 |
Female | 8 (32.0) | 6 (50.0) | ||
Diagnosis before previous PKP | ||||
Bullous keratopathy | 8 (32.0) | 5 (41.7) | 0.66 (0.16–2.73) | 0.57 |
Regraft | 2 (8.0) | 6 (50.0) | 0.09 (0.01–0.54) | 0.0091 |
Corneal scarring | 8 (32.0) | 1 (8.3) | 5.18 (0.57–47.32) | 0.14 |
Corneal dystrophy | 3 (12.0) | 0 (0.0) | – | 1.00 |
Keratoconus | 3 (12.0) | 0 (0.0) | – | 1.00 |
Corneal ulcer | 1 (4.0) | 0 (0.0) | – | 1.00 |
Type of surgery | ||||
PKP | 17 ((68.0) | 10 (83.3) | 0.43 (0.08–2.41) | 0.33 |
PKP + ECCE + IOL | 7 (28.0) | 2 (16.7) | 1.94 (0.34–11.20) | 0.46 |
PKP + IOL suture | 1 (4.0) | 0 (0.0) | – | 1.00 |
history of glaucoma | 5 (20.0) | 3 (25.0) | 0.75 (0.15-3.84) | 0.73 |
Previous episodes of rejection | 1 (4.0) | 4 (33.3) | 0.13 (0.01–1.36) | 0.09 |
ECD before rejection | 1523 ± 666 | 2010 ± 876 | 0.999 (0.998–1.001) | 0.19 |
Interval between PKP and rejection (months) | 41.3 ± 44.2 | 16.8 ± 23.3 | 1.03 (0.99–1.06) | 0.12 |
Interval between rejection and treatment with systemic steroids (days) | 6.5 ± 5.5 | 5.8 ± 6.1 | 1.02 (0.89–1.15) | 0.80 |
Systemic steroid | ||||
Dexamethasone phosphate | 20 (80.0) | 9 (75.0) | 1.33 (0.26–6.83) | 0.73 |
Methylprednisolone | 5 (20.0) | 3 (25.0) | 0.75 (0.15–3.84) | 0.73 |
Interval between treatment and recovery of transparency (days) | 72.5 ± 70.4 | 93.0 ± 208.0 | 0.999 (0.994–1.004) | 0.65 |